-
Most Popular
![Biotech Stocks Icon](https://investorplace.com/wp-content/uploads/2022/12/biotech-150x150.png)
Biotech Stocks
Biotech is defined as using technology to change, manipulate, and harness biological processes in order to fulfill a medical need. The applications of biotech are endless and range from genetically modifying foods to creating vaccines. During the height of the coronavirus pandemic, companies like Moderna and BioNTech utilized biotech to create life-saving vaccines that were distributed across the globe.
![The words "recession proof" written on a pink sticky note. bulletproof stocks](https://investorplace.com/wp-content/uploads/2023/07/shutterstock_2170602547-150x150.jpg)
7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.
![Biochemical/biotech research scientist team working with microscope](https://investorplace.com/wp-content/uploads/2021/12/shutterstock_1726134715-150x150.png)
3 Promising Biotech Stocks for the Long-Term: August 2024
Some of the best biotech opportunities can be found in oversold obesity treatment stocks. Here are just a few.
![Nurse holding a tablet with icons representing different aspects of healthcare and healthcare data representing CANO stock. Healthcare Tech Stocks. Healthcare Stocks to Buy](https://investorplace.com/wp-content/uploads/2022/07/healthcare-1600-150x150.jpg)
The 3 Best Healthcare Stocks to Buy in August 2024
These are the best healthcare stocks that could bring in massive returns to the investors in the future. Do not miss out on this opportunity.
Recent Biotech Stocks Articles
Why Is Replimune (REPL) Stock Down 48% Today?
Replimune stock is dropping on Tuesday as investors in REPL shares react to a clinical trial missing both of its primary endpoints.
Why Is Allarity Therapeutics (ALLR) Stock Up 42% Today?
Allarity Therapeutics stock is rising higher on Tuesday with heavy trading of ALLR stock alongside early clinical trial data.
Why Is iBio (IBIO) Stock Down 41% Today?
Ibio stock is falling on Tuesday after the biotechnology company announced the pricing of its shares in a public offering.
Wealth Accumulation: 3 Stocks with Multibagger Potential
After fears pushed many stocks with great potential to very low levels, it's a great time to buy names that could become multibagger stocks.
Why Is Alterity Therapeutics (ATHE) Stock Up 150% Today?
Although Alterity Therapeutics revealed encouraging data with its PD therapeutic candidate, ATHE stock still faces challenges.
Why Is EyePoint Pharmaceuticals (EYPT) Stock Up 187% Today?
EyePoint Pharmaceuticals stock is rising higher with heavy trading of EYPT on Monday after posting positive results from a clinical trial.
Why Is NLS Pharmaceutics (NLSP) Stock Down 24% Today?
NLS Pharmaceutics stock is falling on Monday after shares of NLSP stock underwent a strong rally with heavy trading on Friday.
Why Is Altimmune (ALT) Stock Up 43% Today?
Altimmune stock is rising higher on Friday with heavy trading of ALT shares after posting positive results form a clinical trial.
Pfizer Layoffs 2023: What to Know About the Latest PFE Job Cuts
Pfizer layoffs are on the way for workers at the company's Groton, Conn. facility as it seeks to reduce costs by cutting jobs.
Why Is NexImmune (NEXI) Stock Up 353% Today?
NexImmune stock is seeing massive gains on Friday with heavy trading of NEXI shares despite a lack of news from the biotechnology company.
Why Is Soligenix (SNGX) Stock Up 285% Today?
Soligenix stock is rising higher on Thursday with heavy trading of SNGX shares after getting FDA approval for a Phase 2 clinical trial.
Income Kings: 7 Blue-Chip Dividend Stocks for Reliable Returns
Are you looking for income kings with reliable returns? Here are seven blue-chip dividend stocks for reliable returns.
Why Is ImmunoGen (IMGN) Stock Up 81% Today?
ImmunoGen stock is taking off on news that AbbVie is acquiring all outstanding shares of IMGN in a $10.1 billion acquisition deal.
Why Is Redhill Biopharma (RDHL) Stock Down 27% Today?
Redhill Biopharma stock is falling on Thursday as shares of RDHL give up some of the gains they made throughout the week.
Why Is Vivos Therapeutics (VVOS) Stock Down 35% Today?
Vivos Therapeutics stock is falling on Thursday but that's only after VVOS shares experienced a massive rally on Wednesday!